Huating Yuan
Overview
Explore the profile of Huating Yuan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
927
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuan H, Liang X, Zhang X, Cao Y
Heliyon
. 2025 Feb;
11(3):e42218.
PMID: 39959484
Accurate annotation of gene function in individual samples and even in each cell type is essential for understanding the pathogenesis of cancers. Single-cell RNA-sequencing (scRNA-seq) provides unprecedented resolution to decipher...
2.
Li Y, Su H, Liu K, Zhao Z, Wang Y, Chen B, et al.
World J Surg Oncol
. 2024 Feb;
22(1):49.
PMID: 38331878
Background: TMPRSS2-ERG (T2E) fusion is highly related to aggressive clinical features in prostate cancer (PC), which guides individual therapy. However, current fusion prediction tools lacked enough accuracy and biomarkers were...
3.
Yan H, Zhu J, Ping Y, Yan M, Liao G, Yuan H, et al.
Stem Cells
. 2022 Dec;
41(2):111-125.
PMID: 36583266
Glioblastoma stem cells (GSCs) contributed to the progression, treatment resistance, and relapse of glioblastoma (GBM). However, current researches on GSCs were performed usually outside the human tumor microenvironment, ignoring the...
4.
Yuan H, Yan M, Liang X, Liu W, He S, Sun S, et al.
Oral Oncol
. 2022 Sep;
134:106110.
PMID: 36087501
Objectives: Systematically identifying cancer cell functional states, especially their associations, is key to understanding the pathogenesis of cancers. Materials And Methods: Here, we systematically identified six cancer-related states, including epithelial-mesenchymal...
5.
Yan M, Hu J, Yuan H, Xu L, Liao G, Jiang Z, et al.
Mol Ther Nucleic Acids
. 2021 Nov;
26:1115-1129.
PMID: 34786214
T cells exhibit heterogeneous functional states, which correlate with responsiveness to immune checkpoint blockade and prognosis of tumor patients. However, the molecular regulatory mechanisms underlying the dynamic process of T ...
6.
Pang L, Hu J, Li F, Yuan H, Yan M, Liao G, et al.
Cancers (Basel)
. 2020 Jan;
11(12).
PMID: 31888172
Single-cell RNA sequencing presents the sophisticated delineation of cell transcriptomes in many cancer types and highlights the tumor heterogeneity at higher resolution, which provides a new chance to explore the...
7.
Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, et al.
Nucleic Acids Res
. 2018 Oct;
47(D1):D900-D908.
PMID: 30329142
High functional heterogeneity of cancer cells poses a major challenge for cancer research. Single-cell sequencing technology provides an unprecedented opportunity to decipher diverse functional states of cancer cells at single-cell...
8.
Deng Y, Luo S, Zhang X, Zou C, Yuan H, Liao G, et al.
Mol Oncol
. 2018 Sep;
12(11):1980-2005.
PMID: 30216655
Substantial cancer genome sequencing efforts have discovered many important driver genes contributing to tumorigenesis. However, very little is known about the genetic alterations of long non-coding RNAs (lncRNAs) in cancer....
9.
Yu F, Quan F, Xu J, Zhang Y, Xie Y, Zhang J, et al.
Brief Bioinform
. 2018 Sep;
20(6):2130-2140.
PMID: 30184043
Breast cancer is a very complex and heterogeneous disease with variable molecular mechanisms of carcinogenesis and clinical behaviors. The identification of prognostic risk factors may enable effective diagnosis and treatment...
10.
Xu L, Deng C, Pang B, Zhang X, Liu W, Liao G, et al.
Cancer Res
. 2018 Aug;
78(23):6575-6580.
PMID: 30154154
: Systematically tracking the tumor immunophenotype is required to understand the mechanisms of cancer immunity and improve clinical benefit of cancer immunotherapy. However, progress in current research is hindered by...